least 20 flanking nucleotides of 29 genes involved in lipoprotein metabolism (including APOB, PCSK9, ANGPTL3, MTTP, MYLIP, and SAR1B) to detect point mutations and small deletions or insertions. Further analysis was done to identify large deletions or duplications. The patient's DNA revealed a variant in intron 4 of MTTP, c.393 + 1A>T, which affects the 3' acceptor splice site, and a heterozygous complete deletion of MTTP (reference sequence NM_000253.3). One variant was confirmed in the DNA of the patient's mother and the other in the DNA of her father. To our knowledge, neither variant has been described before or identified in index cases in our laboratory or in the approximately 120 000 alleles of the Exome Aggregation Consortium database (http://exac.broadinstitute .org).
and targeting policy interventions to reduce admissions that are low-value or discordant with patient preferences.
Objective: To overcome limitations of prior estimates of ICU use (2) by evaluating nationally representative data and examining geographic differences in admission incidence.
Methods and Findings: Using the entire Medicare Provider Analysis and Review file, we evaluated all hospitalizations involving acute and ICU care (including cardiac intensive care but not intermediate care [3] ) between 2006 and 2015 among Medicare fee-for-service beneficiaries aged 65 years or older. We calculated person-years of coverage using the Medicare Provider Analysis and Review Denominator file.
We used data from all 50 states; Washington, DC; and Puerto Rico to assess the relationship between the incidence of ICU admissions and the number of total ICU beds (that is, medical, surgical, and cardiac), estimated using the American Hospital Association Annual Survey Database. For amongstate comparisons, we adjusted ICU admission rates for each state's age and sex distributions using 2010 U.S. Census data. We tested changes over time for counts and proportions using simple Poisson regression and the 2 test for trend, respectively. We reported CIs around count estimates using 95% 2-sided Poisson values. Analyses were performed using SAS (SAS Institute) and the R programming language (R Foundation for Statistical Computing). The Institutional Review Board of the University of Pennsylvania approved this study.
We analyzed claims from 88 402 008 hospitalizations, 14 787 690 (16.7%) of which were associated with ICU care during 289 391 446 person-years of coverage. The ICU admission rate was 6117 per 100 000 person-years (95% CI, 5965 to 6272) in 2006 and decreased to 4247 per 100 000 person-years (CI, 4120 to 4377) in 2015 (P < 0.001). The proportion of hospitalizations that included ICU care also decreased during this period from 17.0% to 16.3% (P < 0.001).
In 2015, we observed a nearly 3-fold difference among state-level ICU admission rates, which ranged from 2117 per 100 000 person-years (CI, 2027 to 2209) in Hawaii to 6312 per 100 000 person-years (CI, 6157 to 6470) in Mississippi. Intensive care unit admission rates decreased in all states except Nebraska, where they increased from 3798 per 100 000 person-years (CI, 3678 to 3921) in 2006 to 3992 per 100 000 person-years (CI, 3869 to 4118) in 2015.
In 2006, the state-level ICU admission rate and number of total beds were positively associated with up to approximately 20 ICU beds per 100 000 person-years ( Figure 1) , with no clear association at greater bed capacities. The association between ICU admissions and number of beds was more strongly positive in 2015, with a monotonically increasing relationship except for 2 regions (Washington, DC, and North Dakota) with many beds and few admissions. Although the national ICU bed count increased by 11.4% between 2006 and 2015, state-level changes ranged from Ϫ38.1% (Rhode Island) to 54.4% (Washington). No association was observed between the percentage of change in ICU beds and admissions across states ( Figure 2) .
Discussion: This nationally representative study shows that ICU admission rates among Medicare fee-for-service beneficiaries have decreased in the past decade. Large, statelevel differences in ICU admission rates were partially associated with ICU bed availability, whereas temporal changes in admission rates were not associated with bed growth. This observation is consistent with previously reported heterogeneity in bed growth and occupancy at the state (4) and hospital (5) levels.
Limitations of this study include the use of Medicare Provider Analysis and Review data, which do not represent populations enrolled in other insurance plans or those without insurance. We also did not adjust for patient-level factors, such as comorbidities, clinician practice patterns, or market competition, which would probably explain some differences in ICU admission rates. The combination of decreased plasma levels of chylomicrons and VLDL can be produced by defects in the gene for either MTTP (*) or apolipoprotein B (APOB) ( †). Defects in MTTP lead to abetalipoproteinemia, and defects in APOB lead to hypobetalipoproteinemia. Defects in the gene for secretion associated Ras related guanosine triphosphatase 1B (SAR1B) (indicated by a double dagger) impair production of chylomicrons but not VLDL and lead to chylomicron retention disease. apo = apolipoprotein; MTTP = microsomal triglyceride transfer protein; TG = triglycerides; VLDL = very-low-density lipoprotein.
Policy and population health strategies to promote highvalue care for Medicare fee-for-service beneficiaries requiring ICU services probably vary among states. The United States has more ICU beds per capita than many peer nations (2); however, bed availability is not the sole driver of ICU admissions and its effects also vary across states. Institution of federal policies governing critical care workforce training, reimbursements for critical care services, and state-level approvals of certificates of need will thus require more local and granular data.
TO THE EDITOR:
As an older general internist, I have lived through the many issues that Downing and colleagues (1) discuss. I remember with some humor that our academic center's intramural news sites circulated a photograph of me at a computer to show that even the oldest among us could learn to use the electronic health record (EHR). I succeeded in mastering the basics; however, facing increasing and seemingly needless requirements and less time with patients (and students, residents, and other learners), I left the struggle. In truth, my failure to meet the local EHR requirements ended my academic practice. The administrative requirements for physicians that are buried in the EHR are now staggering, and the additional requirements inherent in changing reimbursement from a fee-for-service system to a pay-for-performance and value-based one are virtually impossible to fulfill. The authors' points are strong and relevant. 
